Commitments and Contingent Liabilities (Tables)

9 Months Ended

Sep. 30, 2012

Commitments and Contingencies Disclosure [Abstract]

Accretion Of Future Funding Obligation

The future accretion of the noncurrent portion of the liability will total $113 million and be reported as expense in the condensed consolidated statement of income over the period through 2023, as follows (in millions):

Remainder of 2012	$	4
2013	14
2014 – 2023	95
Total	$	113

Litigation Settlements Disclosure

The following table summarizes the impact on PPG’s financial statements for the three and nine months ended September 30, 2012 and 2011 resulting from the 2009 PPG Settlement Arrangement including the change in fair value of the stock to be transferred to the Trust and the equity forward instrument (see Note 15, “Derivative Financial Instruments and Hedge Activities”) and the increase in the net present value of the future payments to be made to the Trust.

	Three Months Ended September 30						Nine Months Ended September 30
Increase (decrease) in expense	2012			2011			2012			2011
	(Millions)
Change in fair value:
PPG stock	$	13		$	(28	)	$	44		$	18
Equity forward instrument	(12		)	28			(45		)	(18		)
Accretion of asbestos liability	2			3			10			9
Asbestos settlement – net expense	$	3		$	3		$	9		$	9